Literature DB >> 27095160

Exploring the association between bipolar disorder and uric acid: A mediation analysis.

Francesco Bartoli1, Cristina Crocamo2, Giulia Maria Gennaro2, Gloria Castagna2, Giulia Trotta2, Massimo Clerici2, Giuseppe Carrà3.   

Abstract

OBJECTIVE: Recent evidence shows that bipolar disorder might be associated with a purinergic system dysfunction. This study aimed at (i) testing the association between bipolar disorder and uric acid serum levels, and (ii) clarifying whether this relationship is mediated by metabolic syndrome and other relevant metabolic parameters.
METHODS: Patients consecutively admitted to a Mental Health Inpatient Unit, with a diagnosis of bipolar disorder or other severe mental disorders, and an appropriate healthy control sample, were included in this cross-sectional, exploratory study. We performed linear regression analyses, to explore factors associated with uric acid levels, and formal tests of mediation to assess mediating effect of candidate variables.
RESULTS: 176 individuals with mental disorders and 89 healthy controls met inclusion criteria. Bipolar disorder was the only diagnostic subgroup significantly associated with increased uric acid levels. Furthermore, male gender, metabolic syndrome, as well as abdominal circumference and triglycerides levels, had a significant effect on uric acid. Relevant mediation analyses showed that the estimated effect between bipolar disorder and uric acid levels was only partially mediated by metabolic abnormalities.
CONCLUSION: This study suggests a direct association between bipolar disorder and uric acid levels, only partially mediated by metabolic abnormalities. It seems consistent with results of previous studies highlighting a purinergic dysfunction in bipolar disorder and the role that purinergic modulators, lowering uric acid levels, could have in clinical practice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Mediation analysis; Metabolic syndrome; Purinergic system; Uric acid

Mesh:

Substances:

Year:  2016        PMID: 27095160     DOI: 10.1016/j.jpsychores.2016.03.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  12 in total

Review 1.  Medical Comorbidities in Bipolar Disorder.

Authors:  Aktriti Sinha; Anam Shariq; Khaled Said; Abhinav Sharma; D Jeffrey Newport; Ihsan M Salloum
Journal:  Curr Psychiatry Rep       Date:  2018-05-07       Impact factor: 5.285

Review 2.  Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression.

Authors:  Francesco Bartoli; Giulia Trotta; Cristina Crocamo; Maria Rosaria Malerba; Massimo Clerici; Giuseppe Carrà
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-15       Impact factor: 5.270

Review 3.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

4.  Serum uric acid is not associated with major depressive disorder in European and South American populations: a meta-analysis and two-sample bidirectional Mendelian Randomization study.

Authors:  Zefeng Chen; Shuang Liang; Yulan Bai; Jiali Lin; Mingli Li; Zengnan Mo; Sisi Xie; ShiShan Huang; Jianxiong Long
Journal:  Eur J Clin Nutr       Date:  2022-05-25       Impact factor: 4.016

5.  Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?

Authors:  Richard J Johnson; William L Wilson; Sondra T Bland; Miguel A Lanaspa
Journal:  Evol Hum Behav       Date:  2020-10-01       Impact factor: 4.178

6.  Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder.

Authors:  Jingxu Chen; Hongmei Chen; Junhui Feng; Ligang Zhang; Juyan Li; Ran Li; Shaoli Wang; Ian Wilson; Alison Jones; Yunlong Tan; Fude Yang; Xu-Feng Huang
Journal:  BMC Psychiatry       Date:  2018-12-18       Impact factor: 3.630

7.  Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Authors:  Jing-Xu Chen; Li-Gang Zhang; Ke-Zhi Liu; Hong-Mei Chen; Shuang-Jiang Zhou; Ning Wang; Yun-Long Tan; Shao-Li Wang; Alison Jones; Fu-De Yang; Xu-Feng Huang
Journal:  Front Psychiatry       Date:  2019-10-31       Impact factor: 4.157

Review 8.  The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

Authors:  Maria Carolina Bittencourt Gonçalves; Roberta Andrejew; Carolina Gubert
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

9.  Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Authors:  Xiudeng Yang; Huai Tao; Ledong Xiao; Cunyan Li; Yamei Tang; Yong Liu
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157

10.  Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Authors:  Zhe Lu; Yingtan Wang; Guanglei Xun
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.